Par Formulations Private Limited 2022-11-23 Health serious FDA
Health · FDA · Recall #FDA-D-0061-2023
Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by:… Recall
Issued November 23, 2022 · Par Formulations Private Limited
In November 2022, Par Formulations Private Limited recalled the Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by:…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Impurities/Degradation Specifications
What you should do
- 1 Stop using Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by:… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Par Formulations Private Limited to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Par Formulations Private Limited
- Category
- Health
- Recall date
- November 23, 2022
- Units affected
- Not reported
- Sold at
- Nationwide within the United States
- Recall number
- FDA-D-0061-2023
- Made in
- India
- Issuing agency
- FDA
In context
- Par Formulations Private Limited has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.